These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 10389923)

  • 21. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
    Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
    Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.
    FitzGerald MG; Marsh DJ; Wahrer D; Bell D; Caron S; Shannon KE; Ishioka C; Isselbacher KJ; Garber JE; Eng C; Haber DA
    Oncogene; 1998 Aug; 17(6):727-31. PubMed ID: 9715274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the PTEN / MMAC1 gene in Japanese patients with Cowden disease.
    Sawada T; Hamano N; Satoh H; Okada T; Takeda Y; Mabuchi H
    Jpn J Cancer Res; 2000 Jul; 91(7):700-5. PubMed ID: 10920277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
    Longy M
    Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.
    George DJ; Shepard TF; Ma J; Giovannucci E; Kantoff PW; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):411-2. PubMed ID: 11319185
    [No Abstract]   [Full Text] [Related]  

  • 29. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PTEN tumour suppressor gene and malignant melanoma.
    Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
    Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in PTEN in breast cancer families.
    Carroll BT; Couch FJ; Rebbeck TR; Weber BL
    J Med Genet; 1999 Feb; 36(2):94-6. PubMed ID: 10051004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1.
    Tsou HC; Ping XL; Xie XX; Gruener AC; Zhang H; Nini R; Swisshelm K; Sybert V; Diamond TM; Sutphen R; Peacocke M
    Hum Genet; 1998 Apr; 102(4):467-73. PubMed ID: 9600246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cowden disease].
    Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.
    Tsou HC; Teng DH; Ping XL; Brancolini V; Davis T; Hu R; Xie XX; Gruener AC; Schrager CA; Christiano AM; Eng C; Steck P; Ott J; Tavtigian SV; Peacocke M
    Am J Hum Genet; 1997 Nov; 61(5):1036-43. PubMed ID: 9345101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations.
    Nelen MR; Kremer H; Konings IB; Schoute F; van Essen AJ; Koch R; Woods CG; Fryns JP; Hamel B; Hoefsloot LH; Peeters EA; Padberg GW
    Eur J Hum Genet; 1999 Apr; 7(3):267-73. PubMed ID: 10234502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
    Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
    J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
    Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
    Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.